Lupin has appointed Brian Savage as President and Chief Legal Officer. He will lead Lupin’s global Legal, Compliance, and Intellectual Property Management Group (IPMG) functions, and will be based in New Jersey.

Savage joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015. Most recently, he served as Teva’s Executive Vice President and Interim Global Chief Legal Officer. During his tenure, he also led Teva’s global litigation strategy and served as General Counsel for its US Generics business.

Prior to joining Teva, he practiced law at Dechert LLP.

Savage brings extensive experience navigating the complex legal and regulatory landscape in the global pharmaceutical industry. He holds a Juris Doctor (JD) from Yale Law School and a BA, summa cum laude, from the University of Pennsylvania.

Commenting on the appointment, Vinita Gupta, CEO, and Nilesh Gupta, Managing Director, Lupin, said, “We are delighted to welcome Brian to our executive leadership team. His deep understanding of the pharmaceutical industry landscape, extensive legal expertise, and proven leadership will be valuable as we continue to strengthen our governance framework, navigate an evolving regulatory environment, and advance our long term growth ambitions.”